NeoGenomics Inc. (NASDAQ: NEO) started the day on March 16, 2023, with a price increase of 4.51% at $19.45. During the day, the stock rose to $19.51 and sunk to $18.143 before settling in for the price of $18.61 at the close. Taking a more long-term approach, NEO posted a 52-week range of $6.00-$19.07.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 16.20%. Meanwhile, its Annual Earning per share during the time was -45.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 21.40%. This publicly-traded company’s shares outstanding now amounts to $124.70 million, simultaneously with a float of $122.24 million. The organization now has a market capitalization sitting at $2.67 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.57, while the 200-day Moving Average is $10.45.
Let’s gauge the efficiency of the firm, which has a total of 2100 employees. For the Profitability, stocks gross margin was +33.99, operating margin was -29.55 and Pretax Margin of -31.26.
NeoGenomics Inc. (NEO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. NeoGenomics Inc.’s current insider ownership accounts for 0.80%, in contrast to 90.80% institutional ownership.
NeoGenomics Inc. (NEO) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2022, the organization reported -$0.14 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.21) by $0.07. This company achieved a net margin of -28.30 while generating a return on equity of -13.70. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
NeoGenomics Inc.’s EPS increase for this current 12-month fiscal period is 21.40% and is forecasted to reach -0.23 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.30% through the next 5 years, which can be compared against the -45.90% growth it accomplished over the previous five years trading on the market.
NeoGenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
Let’s observe the current performance indicators for NeoGenomics Inc. (NEO). It’s Quick Ratio in the last reported quarter now stands at 6.50. The Stock has managed to achieve an average true range (ATR) of 1.09. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.24.
In the same vein, NEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.16, a figure that is expected to reach -0.15 in the next quarter, and analysts are predicting that it will be -0.23 at the market close of one year from today.
Technical Analysis of NeoGenomics Inc. (NEO)
If we take a close look at the recent performances of NeoGenomics Inc. (NASDAQ: NEO), its last 5-days Average volume was 1.22 million that shows progress from its year to date volume of 1.06 million. During the previous 9 days, stock’s Stochastic %D was recorded 88.83% While, its Average True Range was 1.15.
Raw Stochastic average of NeoGenomics Inc. (NEO) in the period of the previous 100 days is set at 99.56%, which indicates a major rise in contrast to 98.50% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 56.43% that was lower than 85.14% volatility it exhibited in the past 100-days period.